“Creatine increases physical performance in successive bursts of short-term, high intensity exercise.”
Exact wording in the current consolidated Article 13 list. Daily intake, beneficial-effect information and target-audience conditions still apply.


EU + POLAND CLAIM PROFILE
A claim-level interpretation of the authorised creatine performance wording, including the 3 g daily intake, adult high-intensity-exercise audience and the boundary to broader strength, energy and endurance promises.
“Creatine increases physical performance in successive bursts of short-term, high intensity exercise.”
This profile records the cited evidence at the stated date. Re-check the authority source before a final formula, claim, artwork or market-access decision.
INDIVIDUAL COMMISSION RECORD · EN / EU
Current record check required · POL-HC-6365
Original retrieved: 2026-10-13T09:02:10.449Z. This is a register-data check, not legal certification or product approval. Fresh retrieval does not change the authorisation date.
Source checks expire after 24 hours. Reference text remains visible, but an expired or missing receipt is not current evidence. The editorial checklist below has its own historical date.
Open this exact Commission record ↗ · Inspect record evidence →
CONDITIONS OF USE
The food must provide a daily intake of 3 g of creatine.
Information must tell the consumer that the beneficial effect is obtained with a daily intake of 3 g of creatine.
The claim may be used only for foods targeting adults performing high-intensity exercise.
Keep this claim separate from the authorised creatine claim for adults over 55 engaged in regular resistance training, which has its own audience, training-protocol and presentation conditions.
Review the complete presentation and Article 10 information; the claim does not establish that the creatine form, product composition or market placement is compliant.
FROM CONDITION TO PRODUCT EVIDENCE
3 g of creatine daily, matching intake instructions and beneficial-effect information, for adults performing high-intensity exercise.
| Check | Evidence to collect | Common review trap | Reference |
|---|---|---|---|
| CLAIM CONDITIONDocument the 3 g daily creatine intake | The creatine quantity delivered by the food and the recommended daily intake in the label instructions. | The mass of a blend or source material is not automatically 3 g of creatine; the performance claim does not approve the exact creatine form. | Regulation (EU) No 432/2012 ↗ |
| CLAIM CONDITIONCheck the accompanying beneficial-effect information | The label information that the beneficial effect is obtained with a daily intake of 3 g of creatine. | A serving number in a facts table does not by itself demonstrate that the beneficial-effect information is provided. | Regulation (EU) No 432/2012 ↗ |
| CLAIM CONDITIONConfirm the specific target audience and exercise context | Product positioning and copy showing that it targets adults performing high-intensity exercise, with successive short-term bursts preserved in the claim. | Do not borrow the separate over-55 resistance-training claim or broaden this profile to every consumer, endurance or general strength. | Regulation (EU) No 432/2012 ↗ |
| PRODUCT REVIEWReview the complete label and consumer-facing copy | The exact label version, serving instructions, Article 10 information and surrounding headline, images and wording in the target language. | A source-of calculation or an authorised sentence does not assess the complete presentation. Do not assume every surface has identical repetition obligations. | Regulation (EC) No 1924/2006 ↗ |
| PRODUCT REVIEWKeep permission to use the claim separate from product eligibility | The matching register entry and legal act, alongside the exact supplier material/source form and product-category review. | General-use claim status is not approval of a source form, finished formulation or market placement. | EU Register of nutrition and health claims ↗ |
COMMON MARKETING VARIANTS
These are Suppvera’s illustrative review examples, not entries copied from the EU Register. A variant is assessed in its full consumer-facing context.
“Creatine increases physical performance in successive bursts of short-term, high intensity exercise.”
Exact wording in the current consolidated Article 13 list. Daily intake, beneficial-effect information and target-audience conditions still apply.
“Creatine helps improve performance during repeated bouts of short-term, high-intensity exercise.”
A close paraphrase, but equivalence still depends on consumer meaning, the target language and the complete product presentation.
“Creatine for high-intensity training performance.”
The compressed wording omits successive bursts and short duration. Review whether nearby copy restores or broadens the authorised relationship.
RISK EXAMPLES
“Instant energy for every workout.”
Adds immediacy, changes performance to energy and removes the specific exercise pattern and adult audience.
“Builds muscle strength in everyone.”
Strength in a universal audience is not the performance relationship in this profile and must not borrow the separate claim for adults over 55.
“Improves endurance performance.”
General endurance is materially different from successive bursts of short-term, high-intensity exercise.
POLISH MARKET LAYER
Use the current Polish-language wording in the consolidated Union list; do not collapse the repeated-burst, short-duration and high-intensity elements into a generic performance promise.
Keep the 3 g daily intake, beneficial-effect information and adult high-intensity-exercise audience consistent across the Polish label, website, ads and creator briefs.
Do not borrow wording or conditions from the separate authorised claim for adults over 55 engaged in regular resistance training.
EVIDENCE
Claim status, conditions, restrictions and linked legal acts
Authorised Article 13 wording, conditions and scientific-reference IDs
General claims rules, Article 10 information and Article 12 prohibitions
How specific health-claim conditions and mandatory information operate